A new tumorgraft panel to accelerate precision medicine in prostate cancer

BackgroundDespite the significant advances in the management of advanced prostate cancer (PCa), metastatic PCa is currently considered incurable. For further investigations in precision treatment, the development of preclinical models representing the complex prostate tumor heterogeneity are mandato...

詳細記述

書誌詳細

主要な著者:	Claire Béraud, Nadege Bidan, Myriam Lassalle, Hervé Lang, Véronique Lindner, Clémentine Krucker, Julien Masliah-Planchon, Eric Potiron, Philippe Lluel, Thierry Massfelder, Yves Allory, Yolande Misseri
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2023-05-01
シリーズ:	Frontiers in Oncology
主題:	PDX prostate cancer neuroendocine tumors genomic characteristics PARP inhibitor metabolism
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1130048/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!